Skip to main content

Table 2 Microorganism distribution

From: Impact of matrix-assisted laser desorption/ionization time of flight mass spectrometric evaluation on the clinical outcomes of patients with bacteremia and fungemia in clinical settings lacking an antimicrobial stewardship program: a pre-post quasi experimental study

Microorganism

Conventional period

Number (%)

MALDI-TOF period

Number (%)

P Value†

Polymicrobial BSI

36/302 (11.9)

26/254 (10.2)

0.530

Total number of organisms

338

285

 

Gram-positive bacteria

112 (33.1)

92 (32.3)

0.821

Staphylococcus aureus

29 (8.6)

20 (7.0)

0.470

 MRSA

16 (4.7)

12 (4.2)

0.754

 Coagulase-negative staphylococcus

26 (7.7)

14 (4.9)

0.158

Streptococcus spp

16 (4.7)

23 (8.1)

0.087

Enterococcus spp

32 (9.5)

24 (8.4)

0.649

 Other gram-positive bacteria

9 (2.7)

11 (3.9)

0.398

Gram-negative bacteria

208 (61.5)

172 (60.4)

0.762

Escherichia coli

94 (27.8)

81 (28.4)

0.866

Klebsiella spp

45 (13.3)

40 (14.0)

0.794

Acinetobacter spp

16 (4.7)

9 (3.2)

0.318

Enterobacter spp

12 (3.6)

5 (1.8)

0.170

Pseudomonas aeruginosa

6 (1.8)

6 (2.1)

0.765

Citrobacter spp

3 (0.9)

8 (2.8)

0.070

Serratia spp

3 (0.9)

3 (1.1)

> 0.999

Proteus spp

4 (1.2)

4 (1.4)

> 0.999

 Other gram-negative bacteria

25 (7.4)

16 (5.6)

0.371

Yeast

18 (5.3)

21 (7.4)

0.294

 Candida spp

17 (5.0)

21 (7.4)

0.224

Cryptococcus spp

1 (0.3)

0 (0.0)

> 0.999

  1. *Abbreviations: MALDI-TOF matrix-assisted laser desorption/ionization time-of-flight, BSI bloodstream infection, MRSA methicillin resistant Staphylococcus aureus
  2. P-values were calculated using the chi-square or Fisher’s exact test